Favorable Conditions for the Detection of EGFR T790M Mutation Using Plasma Sample in Patients with Non-Small-Cell Lung Cancer.

Kim, Insu; Seol, Hee Yun; Kim, Soo Han; Kim, Mi-Hyun; Lee, Min Ki; Eom, Jung Seop

Kim, Insu; Seol, Hee Yun; Kim, Soo Han; Kim, Mi-Hyun; Lee, Min Ki; Eom, Jung Seop.

Afiliação

Kim I; Department of Internal Medicine, Dong-A University Hospital, Busan 49201, Republic of Korea.
Seol HY; Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan 50612, Republic of Korea.
Kim SH; Department of Internal Medicine, Pusan National University School of Medicine, Busan 49241, Republic of Korea.
Kim MH; Department of Internal Medicine, Pusan National University Hospital, Busan 49241, Republic of Korea.
Lee MK; Department of Internal Medicine, Pusan National University School of Medicine, Busan 49241, Republic of Korea.
Eom JS; Department of Internal Medicine, Pusan National University Hospital, Busan 49241, Republic of Korea.

Cancers (Basel) ; 15(5)2023 Feb 24.

Article em En | MEDLINE | ID: mdl-36900237

Palavras-chave

diagnostic molecular pathology; epidermal growth factor receptor; liquid biopsy; lung cancer; tyrosine kinase inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google